Severe intoxication after phenytoin infusion: A preventable pharmacogenetic adverse reaction

被引:11
作者
Citerio, G
Nobili, A
Airoldi, L
Pastorelli, R
Patruno, A
机构
[1] Azienda Osped San Gerardo Tintori, Dipartimento Anestesia & Rianimaz, Monza, Italy
[2] Ist Ric Farmacol Mario Negri, Milan, Italy
关键词
D O I
10.1212/01.WNL.0000058756.61277.17
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:1395 / 1396
页数:2
相关论文
共 7 条
[1]   Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy [J].
Higashi, MK ;
Veenstra, DL ;
Kondo, LML ;
Wittkowsky, AK ;
Srinouanprachanh, SL ;
Farin, FM ;
Rettie, AE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (13) :1690-1698
[2]   Charcoal hemoperfusion in the treatment of phenytoin overdose [J].
Kawasaki, C ;
Nishi, R ;
Uekihara, S ;
Hayano, S ;
Otagiri, N .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (02) :323-326
[3]   Cytochrome P4502C9 polymorphisms: a comprehensive review of the in-vitro and human data [J].
Lee, CR ;
Goldstein, JA ;
Pieper, JA .
PHARMACOGENETICS, 2002, 12 (03) :251-263
[4]   Genetic polymorphism of the CYP2C subfamily and excessive serum phenytoin concentration with central nervous system intoxication [J].
Ninomiya, H ;
Mamiya, K ;
Matsuo, S ;
Ieiri, I ;
Higuchi, S ;
Tashiro, N .
THERAPEUTIC DRUG MONITORING, 2000, 22 (02) :230-232
[5]   Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy [J].
Odani, A ;
Hashimoto, Y ;
Otsuki, Y ;
Uwai, Y ;
Hattori, H ;
Furusho, K ;
Inui, K .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (03) :287-292
[6]   The effect of genetic polymorphism of cytochrome P450CYP2C9 on phenytoin dose requirement [J].
van der Weide, J ;
Steijns, LSW ;
van Weelden, MJM ;
de Haan, K .
PHARMACOGENETICS, 2001, 11 (04) :287-291
[7]   DETECTION OF CYP2C9 POLYMORPHISM BASED ON THE POLYMERASE CHAIN-REACTION IN CHINESE [J].
WANG, SL ;
HUANG, JD ;
LAI, MD ;
TSAI, JJ .
PHARMACOGENETICS, 1995, 5 (01) :37-42